




Searching News Database: acetaminophen
HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
HSMN NewsFeed - 23 Dec 2019
Lannett Receives FDA Approvals For Two Dosage Strengths Of Butalbital, Acetaminophen And Caffeine Capsules
Lannett Receives FDA Approvals For Two Dosage Strengths Of Butalbital, Acetaminophen And Caffeine Capsules
HSMN NewsFeed - 2 Dec 2019
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
HSMN NewsFeed - 16 Jan 2017
Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors
Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors
HSMN NewsFeed - 16 Nov 2016
Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products
Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products
HSMN NewsFeed - 25 Jan 2016
Piramal Critical Care and Cumberland Pharmaceuticals Announce Launch of Caldolor and Vaprisol Co-Promotion
Piramal Critical Care and Cumberland Pharmaceuticals Announce Launch of Caldolor and Vaprisol Co-Promotion
HSMN NewsFeed - 11 Jan 2016
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
HSMN NewsFeed - 28 May 2014
Mallinckrodt Pharmaceuticals’ New Drug Application Accepted for Review by FDA
Mallinckrodt Pharmaceuticals’ New Drug Application Accepted for Review by FDA
HSMN NewsFeed - 19 Mar 2014
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
HSMN NewsFeed - 26 Nov 2013
Echo Therapeutics Announces Positive CE Mark Regulatory Trial Results of Symphony(R) CGM System
Echo Therapeutics Announces Positive CE Mark Regulatory Trial Results of Symphony(R) CGM System
HSMN NewsFeed - 21 Oct 2013
Bayer's CONTOUR(R) NEXT LINK Cleared For Use With Medtronic's New MiniMed(R) 530G With Enlite(R)
Bayer's CONTOUR(R) NEXT LINK Cleared For Use With Medtronic's New MiniMed(R) 530G With Enlite(R)
HSMN NewsFeed - 8 Nov 2012
Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain
Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain
HSMN NewsFeed - 30 Aug 2012
Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia
Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia
HSMN NewsFeed - 7 May 2012
New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing
New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing
HSMN NewsFeed - 31 Oct 2011
NeurogesX Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer
NeurogesX Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 16 May 2011
Caldolor(R) Clinical Study in Hospitalized Burn Patients Published in Journal of Burn Care & Research
Caldolor(R) Clinical Study in Hospitalized Burn Patients Published in Journal of Burn Care & Research
HSMN NewsFeed - 19 Apr 2011
New Class of Instruments for Flexible Surgery from Apollo Endosurgery(R) Used in Cancer Therapy
New Class of Instruments for Flexible Surgery from Apollo Endosurgery(R) Used in Cancer Therapy
HSMN NewsFeed - 18 Jan 2011
Cadence Pharmaceuticals Announces U.S. Launch and Availability of OFIRMEV (acetaminophen) Injection
Cadence Pharmaceuticals Announces U.S. Launch and Availability of OFIRMEV (acetaminophen) Injection
HSMN NewsFeed - 19 Nov 2010
NeurogesX Receives Qutenza(R)-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
NeurogesX Receives Qutenza(R)-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
HSMN NewsFeed - 10 Aug 2010
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
HSMN NewsFeed - 13 Jul 2010
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
HSMN NewsFeed - 4 Jun 2010
New Data at ASCO Show Novartis Drug Tasigna(R) Surpasses Gleevec(R) for Newly Diagnosed CML Patients
New Data at ASCO Show Novartis Drug Tasigna(R) Surpasses Gleevec(R) for Newly Diagnosed CML Patients
HSMN NewsFeed - 5 Apr 2010
Qutenza(R) (capsaicin) 8% Patch for Treatment of Post-Shingles Pain Now Available
Qutenza(R) (capsaicin) 8% Patch for Treatment of Post-Shingles Pain Now Available
HSMN NewsFeed - 11 Feb 2010
Cadence Pharmaceuticals Receives Complete Response Letter from FDA for Intravenous Acetaminophen NDA
Cadence Pharmaceuticals Receives Complete Response Letter from FDA for Intravenous Acetaminophen NDA
HSMN NewsFeed - 24 Nov 2009
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
HSMN NewsFeed - 23 Nov 2009
Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients
Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients
HSMN NewsFeed - 9 Sep 2009
Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
HSMN NewsFeed - 17 Jul 2009
NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
HSMN NewsFeed - 22 Jun 2009
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
HSMN NewsFeed - 2 Jun 2009
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
HSMN NewsFeed - 14 May 2009
Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
HSMN NewsFeed - 19 Mar 2009
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
HSMN NewsFeed - 19 Feb 2009
QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy
QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy
HSMN NewsFeed - 5 Sep 2008
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
HSMN NewsFeed - 29 May 2008
Charles J. Bramlage Named President of Covidien Pharmaceutical Products Business
Charles J. Bramlage Named President of Covidien Pharmaceutical Products Business
HSMN NewsFeed - 28 May 2008
ADVEXIN(R) Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
ADVEXIN(R) Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
HSMN NewsFeed - 8 May 2008
New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
HSMN NewsFeed - 18 Apr 2008
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
HSMN NewsFeed - 10 Mar 2008
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
HSMN NewsFeed - 11 Jan 2008
Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
HSMN NewsFeed - 16 Nov 2007
FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
HSMN NewsFeed - 12 Nov 2007
NicOx' naproxcinod phase 3 results presented at American College of Rheumatology
NicOx' naproxcinod phase 3 results presented at American College of Rheumatology
HSMN NewsFeed - 11 Oct 2007
McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products
McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products
HSMN NewsFeed - 20 Sep 2007
European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma
European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma
HSMN NewsFeed - 13 Sep 2007
Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
HSMN NewsFeed - 20 Aug 2007
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
HSMN NewsFeed - 19 Jul 2007
Ortho-McNeil, Inc. Settles Patent Infringement Litigation Against Par/Kali
Ortho-McNeil, Inc. Settles Patent Infringement Litigation Against Par/Kali
HSMN NewsFeed - 19 Jul 2007
Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet(R) Patent Litigation
Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet(R) Patent Litigation
HSMN NewsFeed - 19 Oct 2006
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
HSMN NewsFeed - 2 Oct 2006
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
HSMN NewsFeed - 8 May 2006
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
Additional items found! 59

Members Archive contains
59 additional stories matching:
acetaminophen
(Password required)
acetaminophen
(Password required)